GB9806929D0 - MEK inhibiting compounds,compositions containing such compounds and methods of treatment - Google Patents

MEK inhibiting compounds,compositions containing such compounds and methods of treatment

Info

Publication number
GB9806929D0
GB9806929D0 GBGB9806929.7A GB9806929A GB9806929D0 GB 9806929 D0 GB9806929 D0 GB 9806929D0 GB 9806929 A GB9806929 A GB 9806929A GB 9806929 D0 GB9806929 D0 GB 9806929D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
methods
compositions containing
mek inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9806929.7A
Other versions
GB2323845A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709292.8A external-priority patent/GB9709292D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9806929D0 publication Critical patent/GB9806929D0/en
Publication of GB2323845A publication Critical patent/GB2323845A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
GB9806929A 1997-03-31 1998-03-31 MEK inhibiting lactones Withdrawn GB2323845A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4287597P 1997-03-31 1997-03-31
GBGB9709292.8A GB9709292D0 (en) 1997-05-07 1997-05-07 MEK inhibiting compounds,compositions containing such compounds and methods of treatment

Publications (2)

Publication Number Publication Date
GB9806929D0 true GB9806929D0 (en) 1998-05-27
GB2323845A GB2323845A (en) 1998-10-07

Family

ID=26311498

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9806929A Withdrawn GB2323845A (en) 1997-03-31 1998-03-31 MEK inhibiting lactones

Country Status (1)

Country Link
GB (1) GB2323845A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP377198A0 (en) * 1998-05-28 1998-06-18 Fujisawa Pharmaceutical Co., Ltd. Novel compound WF00144
EP1365796A2 (en) 2000-09-01 2003-12-03 Van Andel Institute Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
EP1377312A4 (en) * 2001-03-22 2004-10-06 Andel Inst Van Anthrax lethal factor inhibits tumor growth and angiogenesis
DE10130890A1 (en) * 2001-06-27 2003-01-16 Aventis Pharma Gmbh Eurotinones and derivatives thereof, process for their preparation and use thereof
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
KR101210018B1 (en) 2002-03-08 2012-12-07 에자이 알앤드디 매니지먼트 가부시키가이샤 Macrocyclic compounds useful as pharmaceutical
EP1794137A4 (en) * 2004-09-27 2009-12-02 Kosan Biosciences Inc Specific kinase inhibitors
US8546404B2 (en) 2005-12-13 2013-10-01 Merck Sharp & Dohme Compounds that are ERK inhibitors
JP2009528280A (en) 2006-02-16 2009-08-06 シェーリング コーポレイション Pyrrolidine derivatives as ERK inhibitors
US7601852B2 (en) * 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
AU2008279027B8 (en) 2007-07-25 2014-03-06 Eisai R & D Management Co., Ltd. Multikinase inhibitors for use in the treatment of cancer
EP2260031B1 (en) 2008-02-21 2015-10-07 Merck Sharp & Dohme Corp. Compounds that are erk inhibitors
EP2370568B1 (en) 2008-12-10 2017-07-19 Dana-Farber Cancer Institute, Inc. Mek mutations conferring resistance to mek inhibitors
AU2011221227B2 (en) 2010-02-25 2015-07-09 Dana-Farber Cancer Institute, Inc. BRAF mutations conferring resistance to BRAF inhibitors
CA2791247C (en) 2010-03-09 2019-05-14 Dana-Farber Cancer Institute, Inc. Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
US20150141470A1 (en) 2012-05-08 2015-05-21 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy

Also Published As

Publication number Publication date
GB2323845A (en) 1998-10-07

Similar Documents

Publication Publication Date Title
EP0871444A4 (en) 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
PL323470A1 (en) Application of n-propargil-1-amidoindane (r)-enantionmer, its salts and compositions containing same
IL143921A0 (en) Compositions for the treatment and prevention of tumors and tumor-related disorders
GB9806929D0 (en) MEK inhibiting compounds,compositions containing such compounds and methods of treatment
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
PL339619A1 (en) Compositions containing copolymers of polyphenoles and method of obtaining such compositions
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
HRP970213A2 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
GB9709292D0 (en) MEK inhibiting compounds,compositions containing such compounds and methods of treatment
GB9625398D0 (en) Method of treatment,manufacture,compositions and compounds
AU8147598A (en) 8a-azalides, compositions containing such compounds and methods of treatment
PL326581A1 (en) Herbicidal 3,5-difluoropyridines, method of obtaining them and herbicidal composition containing such compounds
EP1021445A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
GB9317943D0 (en) Treatment of laminitis
AU1082599A (en) 8a-azalides, compositions containing such compounds and methods of treatment
GB9812249D0 (en) 9A-Azalides, compositions containing such compounds and methods of treatment
GB9800455D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
GB9800233D0 (en) 8A-Azalides,compositions containing such compounds and methods of treatment
GB9800457D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment
GB9806417D0 (en) 8A-Azalides, compositions containing such compounds and methods of treatment

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)